Haematological cancer: Dual targeting to defeat resistance
- PMID: 28397824
- DOI: 10.1038/nrclinonc.2017.58
Haematological cancer: Dual targeting to defeat resistance
Comment on
-
The allosteric inhibitor ABL001 enables dual targeting of BCR-ABL1.Nature. 2017 Mar 30;543(7647):733-737. doi: 10.1038/nature21702. Epub 2017 Mar 22. Nature. 2017. PMID: 28329763
References
-
- Nature. 2017 Mar 30;543(7647):733-737 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources